Molgramostim Nebulizer Solution Expanded Access Program Protocol | MicrobiomeTrials← Back to trialsNCT06546098
Molgramostim Nebulizer Solution Expanded Access Program Protocol
AVAILABLEEXPANDED_ACCESS
Trial Details
Locations- University of California, Los Angeles, California, United States
- University Florida Health, Gainesville, Florida, United States
- University of Maryland School of Medicine, Baltimore, Maryland, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke University Hospital, Durham, North Carolina, United States
- WakeMed Raleigh, Raleigh, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- AGH Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
Other microbiome trials you might be interested in
Autoimmune Pulmonary Alveolar Proteinosis
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment wi…
Little Rock, United StatesEst. completion Nov 30, 2023
Pulmonary Alveolar Proteinosis
The major goal of Part A of this study is to establish a National PAP Registry to help make reliable new research tests …
Cincinnati, United StatesEst. completion Dec 2030